Biomind Labs Inc
Research Biomind Labs Inc (BMND) on Bullrun: market cap CAD 54.30M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBMND
- ExchangeNEO
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 54.30M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 104.10K
- Free cash flow-USD 65.96K
Valuation Snapshot
latest market cap is CAD 54.30M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 850.41K | -USD 67.55K | n/a | n/a | USD 36 | USD 728.48K | -USD 1.74M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | CAD 54.30M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Biomind Labs Inc
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine sublingual formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's disease;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biomind Labs Inc's market cap?
Biomind Labs Inc's market capitalization is CAD 54.30M.
What does Biomind Labs Inc do?
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.